Malignant transformation of hepatic adenoma with recurrence after resection

HPB

Volumn 4, Issue 3, 2002, Pages 139-143

  Larson, Kenneth A ^a   Weber, Sharon M ^a   Fong, Yuman ^a   Blumgart, Leslie H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BASEMENT MEMBRANE; BLEEDING; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; HEMANGIOMA; HUMAN; LIVER ADENOMA; LIVER LOBECTOMY; MALE; MALIGNANT TRANSFORMATION; NODULAR HYPERPLASIA; POSTOPERATIVE PERIOD; SOLID TUMOR;

EID: 0036408855     PISSN: 1365182X     EISSN: None     Source Type: Journal    
DOI: 10.1080/136518202760388055     Document Type: Article

References (22)

1. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994;129:712-17.
2. Tesluk H, Lawrie J. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med 1981;105:296-9.
3. Gordon SC, Reddy KR, Livingstone AS, Jeffers LJ, Schiff ER. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Intern Med 1986;105:547-9.
4. Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med 1989;110:489-90.
5. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208:558-64.
6. Belghiti J, Paterson D, Panis Y, Vilgrain V et al. Resection of presumed benign liver tumours. Br J Surg 1993;80:380-3.
7. Weimann A, Ringe B, Klempnauer J, Lamesch P et al. Benign liver tumors: differential diagnosis and indicators for surgery. World J Surg 1997;21:983-90.
8. Reddy KR, Kligerman S, Levi J, Livingstone A et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173-8.
9. Ferrell LD. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol 1993;17:525-9.
10. Tao LC. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation. Cancer 1991;68:341-7.
11. Wilkens L, Bredt M, Flemming P, Schwarze Y et al. Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Mol Diagn 2001;3:68-73.
12. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995;19:13-18.
13. Rooks JB, Ory HW, Ishak KG, Strauss LT et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979;242:644-8.
14. Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 1998;4:388-98.
15. Perret AG, Mosnier JF, Porcheron J, Cuilleron M et al. Role of oral contraceptives in the growth of a multilobular adenoma associated with a hepatocellular carcinoma in a young woman. J Hepatol 1996;25:976-9.
16. Gindhart TD. Liver tumors and oral contraceptives: pathology and pathogenesis. Ann Clin Lab Sci 1978;8:443-6.
17. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000;214:861-8.
18. Paulson EK, McClellan JS, Washington K, Spritzer CE et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 1994;163:113-16.
19. Chung KY, Mayo-Smith WW, Saini S, Rahmouni A et al. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 1995;165:303-8.
20. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995;22:1674-81.
21. Jourdan JL, Stubbs RS. Percutaneous biopsy of operable liver lesions: is it necessary or advisable? N Z Med J 1996;109:469-70.
22. Ruschenburg I, Hofmann M, Diab E, Droese M. Comparison of the DNA content in liver cell adenoma, hepatocellular carcinoma and regenerative nodules. Anticancer Res 2000;20:1861-4.